Drug profile · INN
zolbetuximab-clzb
VYLOY
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
zolbetuximab-clzb (VYLOY) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN zolbetuximab-clzb
Brand VYLOY
Route INJECTION
Formulation INJECTABLE
Frequently asked questions
What is zolbetuximab-clzb?
zolbetuximab-clzb (VYLOY) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for zolbetuximab-clzb?
VYLOY is a marketed brand name for zolbetuximab-clzb. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of zolbetuximab-clzb?
zolbetuximab-clzb has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.